Distributing aluminium foil as harm reduction strategy among people who use drugs in prison
Abstract Objectives: Drug use via inhalation substantially reduces the risk of overdose and blood borne infections when compared to parenteral…
Abstract Objectives: Drug use via inhalation substantially reduces the risk of overdose and blood borne infections when compared to parenteral…
Abstract Background: Patients with chronic hepatitis C virus (HCV) infection are at greater risk of developing metabolic disorders. Obesity is…
Abstract Background: Elimination of hepatitis C virus (HCV) among people who use drugs (PWUD) remains a challenge even in countries…
Abstract Background: Thanks to direct-acting antivirals, hepatitis C virus (HCV) infection can be cured, with similar rates in HCV-infected and…
Abstract Introduction: Glecaprevir/pibrentasvir is approved for treating chronic hepatitis C virus (HCV) genotypes (GT) 1–6. We evaluated real-world effectiveness, safety,…
Abstract Background: Rates of hepatitis C virus (HCV) among women of childbearing age have increased as a result of the…
Abstract Objective: Adverse events of drug therapy Background: Rituximab is a chimeric monoclonal antibody to CD20 that is used to…
Abstract The combined regulation of a network of inhibitory and activating T cell receptors may be a critical step in…
Abstract Introduction and objectives: In the last twenty years, sociological changes and actions aimed at improving the health of inmates…
Abstract Background: Homeless people are at a higher risk of blood-born infectious diseases. The aim of this study was to…